Safety of Herceptin/Trastuzumab in Metastatic Breast Cancer
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Cancer, Metastatic Breast Cancer
Interventions: OTHER: No intervention
Sponsor: Hoffmann-La Roche